Australia's #1 provider of free, online, accredited CPD education

There has been an explosion of knowledge about treatment of COVID-19 in the community, with various updates affecting Australian general practice. Earlier this year the PBAC updated their recommendations again. Across four short, sharp and topical MEDTalks, a vibrant, passionate panel of GPs and an epidemiologist will outline the latest considerations for GPs when deciding which COVID treatment to use, on whom, and when.

Monday, 2 December 2024, 7:00pm - 8:30pm AEDT This webinar, presented by GP Dr Peter Eizenberg, Dr Joanne Eng-Frost (Cardiologist) and A/Prof Michael Woodward (Geriatrician), will help GPs and other primary healthcare providers to better understand the role of RSV vaccination in older adults with comorbidities in Australia.

In this clinical audit, you will review the management of patients with CKD in line with latest Australian guidelines, utilising the 'kidney health check' to identify the condition in at-risk patients as appropriate. You will stage patients' CKD severity in order to guide their management, and develop comprehensive management plans involving lifestyle, diet and pharmacological management strategies.

In this clinical audit, you will identify patients with COPD who have a history of moderate to severe exacerbations in the past 12 months and an increased risk of cardiovascular events. You will consider how your patient’s self-management behaviours, inhaled COPD medications and prescribed non-pharmacological treatments could be further optimised, in line with evidence-based guidelines, to improve symptom control and reduce the risk of further exacerbations.

Having lived with COVID-19 for half a decade, how has the management and treatment landscape changed? Develop a practical understanding of the current state of COVID-19 management and the tools the contemporary GP has at their disposal, through this multimedia activity featuring a series of case studies.

This 1.5-hour educational module explores how to identify affected patients with a family history of cancer and provides an overview of how Familial Cancer Centres can assist these patients through genetic testing and risk management.